Enanta Pharmaceuticals, Inc. Share Price
ENTAEnanta Pharmaceuticals, Inc. Stock Performance
Open $14.15 | Prev. Close $13.91 | Circuit Range N/A |
Day Range $13.64 - $14.15 | Year Range $4.96 - $17.11 | Volume 5,317 |
Average Traded $13.83 |
Enanta Pharmaceuticals, Inc. Share Price Chart
About Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Enanta Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $14.15 | $13.87 | +0.00% |
30-Apr-26 | $14.15 | $13.87 | +0.07% |
29-Apr-26 | $13.51 | $13.86 | +0.98% |
28-Apr-26 | $13.54 | $13.72 | +3.55% |
27-Apr-26 | $13.65 | $13.26 | -0.49% |
24-Apr-26 | $13.20 | $13.32 | -1.41% |
23-Apr-26 | $13.83 | $13.51 | -1.89% |
FAQs on Enanta Pharmaceuticals, Inc. Share Price
Can I buy Enanta Pharmaceuticals, Inc. shares in India?
What is the share price of Enanta Pharmaceuticals, Inc.?
What is the 5 year returns of Enanta Pharmaceuticals, Inc.?
What are the high & low stock price of Enanta Pharmaceuticals, Inc. today?
What is the 52-week high and low of Enanta Pharmaceuticals, Inc. stock?